| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 689222 | Null | 0.000573863872925603 | 0.23882559 |
| NSC 104801 | Cytembena | 0.000610795106687085 | 0.34733412 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.000610795106687085 | 0.37512183 |
| NSC 624191 | Null | 0.000610795106687085 | 0.41004438 |
| NSC 641055 | Null | 0.000610795106687085 | 0.43826208 |
| NSC 661428 | Null | 0.000610795106687085 | 0.44591815 |
| NSC 664266 | Null | 0.000610795106687085 | 0.58070732 |
| NSC 753193 | N-(2-(4-acetylpiperazin-1-yl)ethyl)-3-(3-chloro-5-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazole-1-carboxamide | 0.000967118311825465 | 0.27504828 |
| NSC 165572 | Pyrido[3,2-g]quinoline-2,5,8,10(1H,9H)-tetrone, 1,4,6-trimethyl- | 0.000967118311825486 | 0.040994258 |
| NSC 670283 | 2,2'-Spirobi[2H-benz[f]indene]-5,5'-dione, 1,1',3,3',5,5',6,6',7,7',8,8'-dodecahydro- | 0.000967118311825486 | 0.42537064 |